IP Library Granted Patent US 9,788,560
Granted Patent B2
US 9,788,560 · App. 14/656,736 · Granted Oct 17, 2017

Supplemental food

Inventors: Jennifer Marie Toomey (Brattleboro, NJ); Graham Rigby (Brattleboro, NJ); Paul Schulick (Brattleboro, NJ)
Assignee: The Procter & Gamble Company
A23L1/3002A23K20/10A23K20/158A23K50/40A23L33/105A61K36/185A61K36/28A61K36/324A61K36/53A61K36/61A61K36/82A61K36/906A61K36/9066A61K36/9068A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,788,560
App. No.
14/656,736
Granted
Oct 17, 2017
Kind
B2
Abstract

Supplements for maintaining a healthy immune response include one or more extracts from rosemary, turmeric, green tea, ginger, holy basil, oregano, boswellia, black currant, and clove. The supplements may include an extract of thyme. The supplements may exclude anti-inflammatory drugs and certain anti-inflammatory herbs.

Claims (11)

1. An oral dosage form for maintaining healthy immune response, the oral dosage form comprising about 100 mg supercritical extract of rosemary; about 50 mg hydroethanolic extract of rosemary; about 22 mg supercritical extract of turmeric; about 88 mg hydroethanolic extract of turmeric; about 100 mg extract of green tea; about 54 mg supercritical extract of ginger; about 46 mg hydroethanolic extract of ginger; about 42 mg hydroethanolic extract of holy basil; about 8 mg supercritical extract of holy basil; about 10 mg supercritical extract of oregano; about 10 mg hydroethanolic extract of oregano; about 7 mg supercritical extract of clove; about 10 mg supercritical extract of thyme; about 30 mg black currant; and a carrier.

2. The oral dosage form of claim 1 , wherein the supplement is substantially free of hu zhang extract.

3. The oral dosage form of claim 2 , further comprising boswellia serrata.

4. An oral dosage form for maintaining healthy immune response, the oral dosage form comprising about 100 mg supercritical extract of rosemary; about 50 mg hydroethanolic extract of rosemary; about 22 mg supercritical extract of turmeric; about 88 mg hydroethanolic extract of turmeric; about 100 mg extract of green tea; about 54 mg supercritical extract of ginger; about 46 mg hydroethanolic extract of ginger; about 42 mg hydroethanolic extract of holy basil; about 8 mg supercritical extract of holy basil; about 10 mg supercritical extract of oregano; about 10 mg hydroethanolic extract of oregano; about 7 mg supercritical extract of clove; about 5 mg to about 10 mg supercritical extract of thyme; about 30 to about 50 mg black currant; and a carrier.

5. An oral dosage form for maintaining healthy immune response, the oral dosage form comprising about 100 mg supercritical extract of rosemary; about 50 mg hydroethanolic extract of rosemary; about 25 mg supercritical extract of turmeric; about 100 mg hydroethanolic extract of turmeric; about 100 mg extract of green tea; about 15 mg supercritical extract of ginger; about 60 mg hydroethanolic extract of ginger; about 42 mg hydroethanolic extract of holy basil; about 8 mg supercritical extract of holy basil; about 10 mg supercritical extract of oregano; about 10 mg hydroethanolic extract of oregano; about 7 mg supercritical extract of clove; about 30 mg black currant; and a carrier.

6. The oral dosage form of claim 5 further comprising about 4 mg supercritical extract of chamomile and about 11 mg hydroethanolic extract of chamomile.

7. The oral dosage form of claim 5 further comprising about 150 mg boswellia serrata.

8. A method of moderating the inflammatory response to a transient pro-inflammatory stimulus, comprising administering the oral dosage form of claim 1 to a mammal prior to the mammal encountering the stimulus.

9. The method of claim 8 , wherein the transient pro-inflammatory stimulus is selected from the group consisting of exercise, an allergen, a transient increase in oxidative stress, and combinations thereof.

10. A method of moderating the inflammatory response to a transient pro-inflammatory stimulus, comprising administering the oral dosage form of claim 4 to a mammal prior to the mammal encountering the stimulus.

11. The method of claim 10 , wherein the transient pro-inflammatory stimulus is selected from the group consisting of exercise, an allergen, a transient increase in oxidative stress, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2015
From: TOOMEY, JENNIFER MARIE; RIGBY, GRAHAM ROBERT; SCULICK, PAUL
To: NEW CHAPTER, INC.
Reel/Frame 035156/0963 →
Continuity (2)
Provisional Application 61953105 · Mar 14, 2014
Related Publication 20150257425A1 · Sep 17, 2015